Insulet Corp.

PODD ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $563.5M $463.8M $366.9M $263.9M $231.3M $247.0M $211.5M $152.0M
U.S. Omnipod $317.0M $243.3M $209.7M $132.8M $118.4M $100.2M
International Omnipod $201.7M $146.4M $92.7M $13.5M $6.0M $800.0K
Drug Delivery $44.8M $74.1M $64.5M $17.5M $7.2M $5.8M
Neighborhood Diabetes $0 $0 $0 $83.2M $79.9M $45.2M
Cost of Revenue $193.6M $186.6M $155.9M $130.6M $104.2M $134.7M $119.0M $85.5M
Gross Profit $370.2M $277.2M $211.1M $133.3M $127.1M $112.4M $92.3M $66.7M
Gross Margin 65.7% 59.8% 57.5% 50.5% 55.0% 45.5% 43.7% 43.9%
Operating Expenses
Research & Development $94.8M $75.7M $55.7M $43.2M $27.9M $21.8M $24.4M $21.9M
SG&A Expense $248.0M $84.7M $71.6M $60.4M $57.5M $64.1M $51.2M $44.1M
Operating Income $27.4M $-7.4M $-10.7M $-48.7M $-8.9M $-29.1M $-36.0M $-42.5M
Operating Margin 4.9% -1.6% -2.9% -18.5% -3.8% -11.8% -17.0% -27.9%
Interest Expense $28.9M $21.2M $14.4M $12.7M $14.6M $16.9M $16.4M
Pretax Income $5.2M $-26.6M $-26.8M $-61.4M $-47.9M $-44.9M $-51.7M $-57.0M
Income Tax Expense $1.9M $200.0K $392.0K $212.0K $60.0K $100.0K $212.0K $-11.2M
Net Income $3.3M $-26.8M $-28.9M $-73.5M $-51.5M $-45.0M $-51.9M $-45.8M
Net Margin 0.6% -5.8% -7.9% -27.9% -22.3% -18.2% -24.5% -30.2%
EPS (Basic) $0.06 $-0.46 $-0.48 $-1.29 $-0.93 $-0.83 $-1.08 $-0.98
EPS (Diluted) $0.05 $-0.46 $-0.48 $-1.29 $-0.93 $-0.83 $-1.08 $-0.98
Shares Outstanding (Basic) 58.9M 58.0M 57.3M 57.0M 56.3M 54.9M 48.4M 47.5M
Shares Outstanding (Diluted) 61.0M 58.0M 57.3M 57.0M 56.3M 54.9M 48.4M 47.5M
Dividends Per Share
← Newer Page 2 of 3 Older →